Additionally, ferroptosis-based cancer therapies can be developed using gene technologies that either promote or suppress the expression of important genes, such as p53 and acyl-CoA synthetase long-chain family member 4 (ACSL4). This evidence concerns the gene ACSL4 and cancer.